| Biotechnology Industry | Healthcare Sector | Graydon Bensler CEO | NASDAQ (CM) Exchange | 73017P300 CUSIP |
| US Country | 2 Employees | - Last Dividend | 2 Sep 2025 Last Split | - IPO Date |
Elevai Labs Inc. is a prominent skincare development company that focuses on the design, manufacture, and marketing of advanced skincare products within the United States. Initially established as Reactive Medical Labs Inc., the company underwent a rebranding to Elevai Labs, Inc. in December 2021, a strategic move to better align with its mission and the innovative nature of its offerings. Since its inception in 2020, Elevai Labs has been headquartered in Newport Beach, California, from where it orchestrates its operations with an aim to serve a specific segment of the skincare market. This includes dermatologists, plastic surgeons, medical spa owners, and physicians who specialize in aesthetic and therapeutic skincare solutions. Through its dedication to innovation and quality, Elevai Labs Inc. has positioned itself as a trusted partner for professionals seeking effective post-skincare procedure care serums.
This serum is meticulously designed for the face, neck, and upper chest regions, providing targeted care and recovery support following skincare procedures. Empower serum is acclaimed for its potent formula that aids in enhancing the skin's natural healing processes, thereby ensuring optimal results post-procedure.
Similar to the Empower serum, Enfinity is also crafted for application on the face, neck, and upper chest areas. It is specially formulated to complement the recovery phase of skin following various aesthetic interventions. Enfinity serum stands out for its innovative ingredients that work to restore, rejuvenate, and maintain the skin’s health and appearance, post-procedure.